重组Anti-ZNFX1抗体[EPR12330]
Anti-ZNFX1 antibody [EPR12330]
- RabMAb
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal ZNFX1 antibody. Suitable for WB and reacts with Human samples. Cited in 8 publications.
查看别名
KIAA1404, ZNFX1, NFX1-type zinc finger-containing protein 1
- WB
Supplier Data
Western blot - Anti-ZNFX1 antibody [EPR12330] (AB179452)
All lanes:
Western blot - Anti-ZNFX1 antibody [EPR12330] (ab179452) at 1/1000 dilution
Lane 1:
MCF7 cell lysate at 10 µg
Lane 2:
K562 cell lysate at 10 µg
Lane 3:
HeLa cell lysate at 10 µg
Predicted band size: 220 kDa
false
- WB
Unknown
Western blot - Anti-ZNFX1 antibody [EPR12330] (AB179452)
All lanes:
Western blot - Anti-ZNFX1 antibody [EPR12330] (ab179452) at 1/1000 dilution
All lanes:
K-562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 220 kDa
Observed band size: 220 kDa
false
不同偶联物与剂型 (1)
-
Anti-ZNFX1 antibody [EPR12330] - BSA and Azide free
反应性数据
产品详情
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ZNFX1 influences immune function and viral defense mechanisms. Acting within ribonucleoprotein complexes it participates in the sensing of double-stranded RNA an indicator of viral infection. ZNFX1 helps modulate type I interferon responses a critical aspect of host defense. In these processes it interacts with other proteins necessary for the immune system contributing to maintaining cellular immune surveillance and controlling viral replication.
Pathways
The actions of ZNFX1 integrate into pathways related to RNA processing and immune responses. Specifically ZNFX1 is involved in the RIG-I-like receptor (RLR) pathway which is important for antiviral responses. In this pathway ZNFX1 interacts with proteins like RIG-I and MAVS to facilitate the proper functioning of antiviral signaling cascades. This pathway's coordination leads to the activation of transcription factors that promote the expression of type I interferons and other cytokines essential for antiviral immunity.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (8)
Recent publications for all applications. Explore the full list and refine your search
The EMBO journal 43:5469-5493 PubMed39333773
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of hematology & oncology 17:77 PubMed39218923
2024
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 9: PubMed38016036
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 14:1280668 PubMed37901206
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of medical virology 95:e28637 PubMed36892175
2023
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 14: PubMed35891387
2022
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 118: PubMed33876776
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 55:896-904 PubMed31432148
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com